GlassScriptPhysician profile
Buthaina M Jabir
NPI 1225241979
$199,251.39
in general payments reported to CMS, 2019-2025
31 companies · $651 in 2025
The $651 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $16K · 2021: $33K · 2022: $21K · 2023: $47K · 2024: $57K · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $89K · Food and Beverage: $7,393 · Travel and Lodging: $7,241 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $88,500.00 |
| Food and Beverage | $7,393.16 |
| Travel and Lodging | $7,241.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $136,524.12 | 2019-2024 | Da Vinci Surgical System, Davinci Xi |
| Merck Sharp & Dohme LLC | $29,542.85 | 2019-2021 | |
| Organon LLC | $27,476.20 | 2021-2025 | Nexplanon |
| Boston Scientific Corporation | $1,071.58 | 2023-2024 | Upsylon |
| Hologic Sales and Service, LLC | $741.22 | 2021-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Baxter Healthcare | $594.39 | 2020-2024 | Tisseel, Perclot |
| Novo Nordisk INC | $403.77 | 2019-2022 | |
| Axonics, INC. | $304.98 | 2022-2024 | Bulkamid, Axonics |
| Gynesonics, INC. | $287.30 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $274.77 | 2019-2022 | |
| Abbvie INC. | $247.73 | 2019 | |
| Dysis Medical, INC. | $221.83 | 2019-2020 | |
| Lupin INC. | $202.93 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $201.49 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $185.92 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $177.26 | 2023 | Megadyne, Surgiflo Hemostatic Matrix, Echelon Flex |
| Aspira Women'S Health INC | $106.45 | 2021-2022 | |
| Agile Therapeutics, INC. | $104.81 | 2021 | |
| Tactile Systems Technology INC | $98.49 | 2021 | |
| Astellas Pharma US INC | $72.39 | 2019-2024 | Veozah |
| Therapeuticsmd, INC. | $66.62 | 2019-2020 | |
| Shield Therapeutics INC | $60.20 | 2024-2025 | |
| Conmed Corporation | $53.46 | 2019-2023 | Airseal |
| Aesculap, INC. | $40.42 | 2019 | |
| Myovant Sciences INC. | $35.91 | 2021-2022 | |
| Medtronic, INC. | $34.12 | 2023 | V-Loc 180 |
| Duchesnay USA Incorporated | $31.31 | 2019 | |
| Mylan Pharmaceuticals INC. | $29.88 | 2022 | |
| Exeltis, USA INC. | $28.10 | 2019-2025 | Slynd |
| Acessa Health INC. | $16.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Buthaina Jabir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.